Cancer Biomarkers

Papers
(The H4-Index of Cancer Biomarkers is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
RAB27B expression in pancreatic cancer is predictive of poor survival but good response to chemotherapy78
miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway72
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification59
Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms39
The clinical significance and function of EGFR mutation in TKI treatments of NSCLC patients37
Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery28
Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer28
The effect of low-intensity resistance exercise training on Serum tumor biomarkers and quality of life in women with breast cancer: A randomized controlled trial23
Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies23
Machine learning identifies a 5-serum cytokine panel for the early detection of chronic atrophy gastritis patients21
Identification of TNFRSF1A as a potential biomarker for osteosarcoma20
High TCTA expression is an adverse prognostic biomarker in acute myeloid leukemia17
Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma17
Erratum to: Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells16
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients14
YTHDF1 amplification is correlated with worse outcome and lower immune cell infiltrations in breast cancer14
Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer14
0.51652693748474